NCT05991115 Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care
| NCT ID | NCT05991115 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kavita Parikh |
| Condition | Asthma |
| Study Type | INTERVENTIONAL |
| Enrollment | 340 participants |
| Start Date | 2024-01-22 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 340 participants in total. It began in 2024-01-22 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Caregiver-child dyads will be recruited during child's hospital admission for asthma exacerbation. Recruitment sites will be mainly Children's National Hospital Sheikh Zayed campus, as well as regional partners: Holy Cross Hospital, and Mary Washington Hospital. After enrollment, baseline data will be collected from caregiver. Caregiver-child dyads will be randomized (1:1 ratio) into the control arm or intervention arm. Control arm will receive the standard of care after hospital discharge. Intervention arm will receive the SOC plus an asthma navigator support after hospital discharge. Caregivers in both arms will complete data collection surveys (either in-person or via telehealth) at 3-,6-, 9-, and 12- month post enrollment.
Eligibility Criteria
Inclusion Criteria: 1. speak English or Spanish 2. are at least 18 years old 3. live in the District of Columbia, Maryland, or Virginia (DMV) 4. have a child aged 4-12 years who is hospitalized due to asthma exacerbation. Exclusion Criteria: 1. . Children ages 4-12 years with chronic medical condition (other than asthma) including but not limited to diabetes, sickle cell disease, heart disease, lung disease or neurological disorder 2. . Children ages 4-12 years involved in interventions with behavioral component and/or novel asthma therapeutics will be excluded given overlap with the current intervention 3. . Children ages 4-12 years in foster care 4. . Families not residing in the DMV 5. . Caregivers who do not speak English or Spanish
Contact & Investigator
Kavita Parikh, MD MSHS
PRINCIPAL INVESTIGATOR
Children's National Research Institute
Frequently Asked Questions
Who can join the NCT05991115 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 12 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05991115 currently recruiting?
Yes, NCT05991115 is actively recruiting participants. Contact the research team at kparikh@childrensnational.org for enrollment information.
Where is the NCT05991115 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT05991115 clinical trial?
NCT05991115 is sponsored by Kavita Parikh. The principal investigator is Kavita Parikh, MD MSHS at Children's National Research Institute. The trial plans to enroll 340 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.